Hematology

Latest News

PNH. | Image Credit: Innovative Creation -  stock.adobe.com
Biosimilar SB12 Matches Eculizumab in PNH Treatment Across Diverse Patient Groups

July 3rd 2025

Biosimilar SB12 demonstrated comparable efficacy and safety for paroxysmal nocturnal hemoglobinuria (PNH) to its reference drug, showing similar outcomes across diverse patient groups.

kidney care and aHUS | Image credit: kanruthaiHUS - stock.adobe.com
Biosimilars Offer New Hope for European Patients Facing High Eculizumab Costs

May 20th 2025

paroxysmal nocturnal hemoglobinuria | Image credit: olegganko - stock.adobe.com
Teva and Samsung Bioepis Launch Biosimilar Epysqli

April 9th 2025

red blood cells | Image credit: olegganko - stock.adobe.com
Long-Term Data Support Use of Eculizumab Biosimilar as Soliris Alternative in PNH

January 28th 2025

eye on pharma banner
Eye on Pharma: Korean Drugmakers’ Impact in Europe; New Denosumab, Eculizumab Deals

January 11th 2025

Video Interviews
Podcasts
canadian flag on a mountain

More News

© 2025 MJH Life Sciences

All rights reserved.